Compound information
- Natural Products
- ZC322126
- Molecular Formula
- C11H15ClN2O3S
- Molecular Weight
- 290.04919102 g/mol
- Structure
-
- IUPAC Name
- 2-chloro-N-[3-(dimethylsulfamoyl)-4-methyl-phenyl]acetamide
- InChI
- InChI=1S/C11H15ClN2O3S/c1-8-4-5-9(13-11(15)7-12)6-10(8)18(16,17)14(2)3/h4-6H,7H2,1-3H3,(H,13,15)
- InChI Key
- ZIIIFUAOQPEVPU-UHFFFAOYSA-N
- SMILES
- Cc1ccc(NC(=O)CCl)cc1S(=O)(=O)N(C)C
- Source
- ZINC000003885308
Warheads
- Halohydrocarbon
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 18 | Ring Count | 1 |
Heteroatom Count | 7 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 66.48 Å2 | LogP | 1.442 |
LogS | -2.971 | LogD | 1.782 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.055 | Pgp substrate | 0.307 |
HIA | 0.961 | F20 % | 0.988 |
F30 % | 0.945 | Caco-2 | -5.329 |
MDCK | -5.46 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.188 | PPB | 97.662 |
VD | 0.939 | Fu | 0.685 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.833 | CYP1A2 substrate | 0.74 |
CYP2A6 substrate | 0.802 | CYP2B6 substrate | 0.688 |
CYP2C19 inhibitor | 0.632 | CYP2C19 substrate | 0.893 |
CYP2C8 substrate | 0.848 | CYP2C9 inhibitor | 0.391 |
CYP2C9 substrate | 0.999 | CYP2D6 inhibitor | 0.044 |
CYP2D6 substrate | 0.943 | CYP2E1 substrate | 0.932 |
CYP3A4 inhibitor | 0.287 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.369 | CL | 12.031 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.168 | Hepatotoxicity | 0.944 |
Mutagenicity | 0.04 | Rat Oral Acute Toxicity | 0.108 |
FDAMDD | 0.129 | Skin Sensitization | 0.988 |
Carcinogenicity | 0.521 | Eye Corrosion | 0.373 |
Eye Irritation | 0.159 | Respiratory Toxicity | 0.977 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.555 | IGC50 | 3.18 |
LC50FM | 4.026 | LC50DM | 4.333 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.118 | NR-AR-LBD | 0.4 |
NR-AhR | 0.766 | NR-Aromatase | 0.719 |
NR-ER | 0.349 | NR-ER-LBD | 0.524 |
NR-PPAR-gamma | 0.906 | SR-ARE | 0.976 |
SR-ATAD5 | 0.576 | SR-HSE | 0.896 |
SR-MMP | 0.336 | SR-p53 | 0.866 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.